GlassScriptPhysician profile
Charlecinth M Roberts
NPI 1700105624
$7,814.90
in general payments reported to CMS, 2019-2025
43 companies · $1,628 in 2025
The $1,628 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $426 · 2021: $684 · 2022: $1,122 · 2023: $1,445 · 2024: $1,638 · 2025: $1,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,705 · Education: $5.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,705.28 |
| Education | $5.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,702.77 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $713.69 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $662.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $606.90 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $606.52 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Glaxosmithkline, LLC. | $420.27 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $397.94 | 2019-2025 | Xifaxan |
| Amgen INC. | $330.75 | 2019-2025 | Otezla, Repatha, Krystexxa |
| Lundbeck LLC | $312.97 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $280.01 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $262.02 | 2019-2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $236.02 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $164.45 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Abbott Laboratories | $101.67 | 2020-2025 | Freestyle Libre 3 |
| Shield Therapeutics INC | $90.91 | 2023-2025 | Accrufer |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charlecinth Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.